Preclinical data demonstrate >90% reduction in human cytomegalovirus (HCMV) reactivation from latency, establishing proof-of-concept for SYN002 in human kidneys -- Data published in the American ...
3hon MSN
Turn an average sentence into a standout phrase with two-year access to MasterWriter for $100
TL;DR: Give yourself a writing upgrade with this two-year license to the Creative Writer version of MasterWriter, now for ...
Asianet Newsable on MSN
Theriva™ Biologics licenses SYN-020 to Rasayana Therapeutics for multiple indications
Theriva received a $300,000 upfront payment at signing and is eligible for up to $38M in development, regulatory, and sales ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results